^
BIOMARKER:

PALB2 mutation

i
Other names: PALB2, Partner And Localizer Of BRCA2, FANCN, Truncated Partner And Localizer Of BRCA2, Fanconi Anemia, Complementation Group N, Mutant Partner And Localizer Of BRCA2, PNCA3
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
Related biomarkers:
PALB2 mutation
Pancreatic Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
A2
PALB2 mutation
Prostate Cancer
olaparib
Sensitive
:
A2
PALB2 mutation
HER2 Negative Breast Cancer
talazoparib
Sensitive
:
A2
PALB2 mutation
HER2 Negative Breast Cancer
olaparib
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
rucaparib
Sensitive
:
A2
PALB2 mutation
Pancreatic Adenocarcinoma
FOLFIRINOX
Sensitive
:
A2
PALB2 mutation
Ovarian Cancer
olaparib
Sensitive
:
B
PALB2 mutation
Breast Cancer
CX-5461
Sensitive
:
B
PALB2 mutation
Ovarian Cancer
CX-5461
Sensitive
:
B
PALB2 mutation
Pancreatic Cancer
ABT-888
Sensitive
:
C2
PALB2 mutation
Pancreatic Cancer
rucaparib
Sensitive
:
C2
PALB2 mutation
Breast Cancer
olaparib
Sensitive
:
C2
PALB2 mutation
Urothelial Cancer
olaparib
Sensitive
:
C2
PALB2 mutation
HER2 Negative Breast Cancer
durvalumab
Sensitive
:
C2
PALB2 mutation
Triple Negative Breast Cancer
everolimus
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
PALB2 mutation
Hormone Receptor Positive Breast Cancer
lenvatinib
Resistant
:
C3
PALB2 mutation
Pancreatic Cancer
oxaliplatin
Sensitive
:
C3
PALB2 mutation
Prostate Cancer
PARP inhibitor
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
ipilimumab + niraparib
Sensitive
:
C3
PALB2 mutation
Endometrial Cancer
rucaparib + E 3810
Sensitive
:
C4
PALB2 mutation
Triple Negative Breast Cancer
carboplatin + docetaxel
Sensitive
:
D